Survival Benefit of Tamoxifen in Estrogen Receptor-Negative and Progesterone Receptor-Positive Low Grade Breast Cancer Patients

@inproceedings{Yang2012SurvivalBO,
  title={Survival Benefit of Tamoxifen in Estrogen Receptor-Negative and Progesterone Receptor-Positive Low Grade Breast Cancer Patients},
  author={Li-Heng Yang and H S Tseng and Che Lin and Li-sheng Chen and Shou-Tung Chen and S E Kuo and Dar-Ren Chen},
  booktitle={Journal of breast cancer},
  year={2012}
}
PURPOSE This study aimed to analyze the efficacy and prognostic significance of adjuvant tamoxifen in breast cancer patients with various hormone receptor statuses. METHODS Typically, 1,260 female breast cancer patients were recruited in this study. The correlation between estrogen receptor (ER)/progesterone receptor (PR) phenotypes and clinical characteristics was investigated, and the survival rate was assessed after 5-year follow-up. RESULTS The 5-year overall survival (85%) was better… CONTINUE READING
16 Citations
28 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 28 references

Role of the progesterone receptor (PR) and the PR isoforms in breast cancer

  • O Mc Cormack, M Harrison, MJ Kerin, A. McCann
  • Crit Rev Oncog 2007;13:283-301
  • 2007
1 Excerpt

Similar Papers

Loading similar papers…